BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.25%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.01B
AUM Growth
+$1.01B
(+5.4%)
Cap. Flow
+$23.9M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
32.72%
Holding
140
New
6
Increased
28
Reduced
48
Closed
16
Top Buys
| 1 |
Teladoc Health
TDOC
|
$18.9M |
| 2 |
Humana
HUM
|
$13.5M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$12.7M |
| 4 |
Esperion Therapeutics
ESPR
|
$11.9M |
| 5 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
$11.7M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$20.4M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.6M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$9.94M |
| 5 |
Tenet Healthcare
THC
|
$9.34M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Industrials | 0.39% |
| 3 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Align Technology
ALGN
$10.3B
| $40.5M | 4.02% | 161,388 -12,208 | -7% | -$3.07M |
|
2
Elevance Health
ELV
$71.8B
| $39.8M | 3.94% | 181,243 | – | – |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $38.8M | 3.84% | 434,400 +30,135 | +7% | +$2.69M |
|
4
Intuitive Surgical
ISRG
$170B
| $34.1M | 3.38% | 82,590 -13,541 | -14% | -$5.59M |
|
5
Abbott
ABT
$231B
| $33.9M | 3.35% | 565,000 +35,000 | +7% | +$2.1M |
|
6
UnitedHealth
UNH
$281B
| $30.5M | 3.02% | 142,590 -320 | -0.2% | -$68.5K |
|
7
Illumina
ILMN
$15.8B
| $30.1M | 2.98% | 127,273 -22,600 | -15% | -$5.34M |
|
8
Medtronic
MDT
$119B
| $28.6M | 2.84% | 357,000 +140,000 | +65% | +$11.2M |
|
9
Edwards Lifesciences
EW
$47.8B
| $27.5M | 2.73% | 197,160 +8,960 | +5% | +$1.25M |
|
10
DexCom
DXCM
$29.5B
| $26.4M | 2.62% | 356,390 +89,650 | +34% | +$6.65M |
|
11
Jazz Pharmaceuticals
JAZZ
$7.75B
| $22.9M | 2.27% | 151,722 -3,860 | -2% | -$583K |
|
|
12
Humana
HUM
$36.5B
| $22.5M | 2.23% | 83,700 +50,350 | +151% | +$13.5M |
|
|
13
Teladoc Health
TDOC
$1.37B
| $20.8M | 2.06% | 515,694 +468,694 | +997% | +$18.9M |
|
14
Danaher
DHR
$147B
| $19.8M | 1.96% | 202,000 | – | – |
|
15
Incyte
INCY
$16.5B
| $19.2M | 1.9% | 230,626 -950 | -0.4% | -$79.2K |
|
16
Boston Scientific
BSX
$156B
| $19M | 1.88% | 696,000 | – | – |
|
17
Cencora
COR
$56.5B
| $18.6M | 1.84% | 215,178 +4,237 | +2% | +$365K |
|
18
Stryker
SYK
$150B
| $18.2M | 1.81% | 113,300 +22,000 | +24% | +$3.54M |
|
19
Hologic
HOLX
$14.9B
| $18.1M | 1.79% | 483,894 | – | – |
|
|
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
| $17.3M | 1.71% | 263,560 -33,000 | -11% | -$2.16M |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $15.8M | 1.56% | 96,810 +600 | +0.6% | +$97.8K |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $14.6M | 1.45% | 131,390 +620 | +0.5% | +$69.1K |
|
23
MacroGenics
MGNX
$112M
| $14.2M | 1.4% | 563,151 -1,250 | -0.2% | -$31.5K |
|
24
Baxter International
BAX
$12.7B
| $14M | 1.39% | 216,000 | – | – |
|
25
Ionis Pharmaceuticals
IONS
$6.79B
| $13.8M | 1.36% | 312,186 +55,480 | +22% | +$2.45M |
|